Express News | NYSE Order Imbalance 120851.0 Shares on Sell Side
ReutersApr 26 15:50 ET
AbbVie Stock Slides 6% Amid Concerns About Falling Humira Sales
Seeking AlphaApr 26 14:09 ET
Cigna to Offer Humira Rivals With $0 Copay at Specialty Pharmacy
Yahoo FinanceApr 25 16:30 ET
Express News | NYSE Order Imbalance 133734.0 Shares on Sell Side
ReutersApr 25 15:50 ET
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of Its Petition in HETLIOZ ANDA Litigation
Yahoo FinanceApr 22 19:12 ET
Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court
Vanda Pharmaceuticals' (VNDA) appeal to revive patent protections for its Hetlioz sleep-disorder medication was declined by the US Supreme Court, upholding a decision in favor of generic drugmakers Te
MT NewswiresApr 22 16:11 ET
Express News | NYSE Order Imbalance 57025.0 Shares on Sell Side
Moomoo 24/7Apr 22 15:50 ET
US Supreme Court Reportedly Declines to Hear Vanda Patent Case
Seeking AlphaApr 22 10:55 ET
U.S. Supreme Court Rejects Vanda Pharmaceuticals Case Over Sleep-drug Patents
Yahoo FinanceApr 22 09:54 ET
Peptide Therapeutics Analysis Report 2024 - Global Forecast to 2030 Featuring Eli Lilly and Co, Pfizer, Amgen, Takeda, AstraZeneca, Teva, Sanofi, F. Hoffmann-La Roche, Novartis, Novo Nordisk
Yahoo FinanceApr 22 04:14 ET
Express News | NYSE Order Imbalance 82586.0 Shares on Sell Side 82586.0 Shares on Sell Side
Moomoo 24/7Apr 19 15:50 ET
Alvotech, Teva Signs Deal to Expand Access for Humira Biosimilar in U.S.
Seeking AlphaApr 19 06:55 ET
Alvotech Inks Long-Term Agreement With A Strategic Partner To Further Enhance Access To Adalimumab-ryvk In US Market
"This new partnership agreement supports our financial guidance and reflects Alvotech's strong commitment to increasing patient access to more affordable healthcare," said Robert Wessman, Chairman and
BenzingaApr 19 06:11 ET
Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris
Yahoo FinanceApr 19 06:00 ET
Express News | Teva Pharmaceuticals Decided That Canada Will No Longer Be Included As Part Of Teva's North America Segment As Of Jan. 1, 2024
Moomoo 24/7Apr 18 16:09 ET
Express News | NYSE Order Imbalance 90302.0 Shares on Buy Side 90302.0 Shares on Buy Side
Moomoo 24/7Apr 18 15:50 ET
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
Yahoo FinanceApr 18 11:12 ET
CVS Favors Humira Copycats Hurting AbbVie's Market Share: Evercore
Seeking AlphaApr 17 09:26 ET
Alvotech, Teva Get FDA Approval for Stelara Biosimilar Psoriasis Treatment
Alvotech and Teva Pharmaceuticals said the Food and Drug Administration approved the Selarsdi injection for subcutaneous use as a biosimilar to Stelara for the treatment of psoriasis.
WSJApr 16 19:52 ET
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI (Ustekinumab-aekn), Biosimilar to Stelara (Ustekinumab)
Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara.
GlobeNewswireApr 16 17:30 ET
No Data
No Data